430 / 1498
RT in GHSG BEACOPP Studies (1)
•
HD 9 established the advantage of escalated BEACOPP. It included
30-40 Gy IFRT to over 2/3 of patients (bulky and/or residual
disease).
•
In HD 12 esc. BEACOPP cycle reduction and randomization to +/- RT
were studied.
•
Less esc. BEACOPP was inferior to 8 esc. BEACOPP, but not less
toxic.
•
FFTP was inferior with no RT particularly if residual CT abnormality.
“Our results do not support the omission of consolidation RT for
patients with residual disease”.
.
26